MICHAEL BEAVERS: Open Payments
NPI 1588225106 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 34 payments from 18 companies in 2025. Trend: 2023 $351 · 2024 $1,006 · 2025 $792
Food & beverage: $792
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $192 |
| Viatris Specialty LLC | 3 | $84 |
| Exact Sciences Corporation | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| Lilly USA, LLC | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| ABBVIE INC. | 2 | $41 |
| Antares Pharma, Inc. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
Products named: BREZTRI, YUPELRI, LEQVIO, FARXIGA, The Cologuard Plus Collection Kit, CAPLYTA, VRAYLAR, MOUNJARO.
Industry payments across SC — which companies pay providers there.
